- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01817829
Oral Paracetamol as Preemptive Analgesia for Labor Pain
March 21, 2013 updated by: Ahmed Elsayed Hassan Elbohoty, Ain Shams University
It is a double blinded randomized control trial assessing the use of Oral paracetamol in managing the intrapartum pain.
Study Overview
Detailed Description
It is a double blinded randomized control trial comparing the use of Oral paracetamol to placebo in managing the intrapartum pain.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- primigravida
- The gestational age between 37- 42 weeks
- Not seeking analgesia
- Singleton pregnancy
- vertex
- Spontaneous onset of labour
- 1st stage of labour (less than 5 cm)
Exclusion Criteria:
- Extreme of age (below18-above 40)
- Multiparous
- Multiple gestation
- Malpresentation
- Congenital or acquired pelvic abnormalities(eg. Poliomyelitis)
- Any medical disorder with pregnancy
- Induction of labour
- Advanced 1st stage > 5 cm
- Use of any other kind of analgesia before recruitment in the study
- Scared uterus
- Fetal distress
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: paracetamol
paracetamol 2 tablets1000mg PO.
|
500 mg oral tablet
|
|
Placebo Comparator: placebo
placebo 2 tablets containing Starch PO
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy
Time Frame: intrapartum
|
To document the efficacy of oral paracetamol, in pregnant women in labor, as demonstrated by the degree of pain relief and need for additional analgesia during the labor process and the early postpartum period.
|
intrapartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety
Time Frame: Start of medication till 24 hours postpartum
|
To document safety and evaluate adverse events recorded during the study either maternal or fetal.
|
Start of medication till 24 hours postpartum
|
|
Duration of labor
Time Frame: Start of medication till delivery of fetus.
|
To assess the effect of the duration of labor.
|
Start of medication till delivery of fetus.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
February 4, 2013
First Submitted That Met QC Criteria
March 21, 2013
First Posted (Estimate)
March 26, 2013
Study Record Updates
Last Update Posted (Estimate)
March 26, 2013
Last Update Submitted That Met QC Criteria
March 21, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OPPALP
- Personal (Ain Shams)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor Pain
-
Antalya Bilim UniversityCompletedChildbirth | Normal Labor | Labor Pain and to Reduce PainTurkey (Türkiye)
-
Pınar ErdoğanCompletedLabor Progress | Labor Pain and AnxietyTurkey (Türkiye)
-
Soovu Labs Inc.Virginia Mason Hospital/Medical CenterNot yet recruiting
-
Bogomolets National Medical UniversityCompleted
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
Maimonides Medical CenterTerminated
-
Cairo UniversityNot yet recruiting
-
Aretaieio HospitalRecruitingLabor Pain | Pain, Labor | EpiduralGreece
-
Mashhad University of Medical SciencesTerminatedDecrease Labor Pain
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AkesoNot yet recruitingAtopic DermatitisChina
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States